Aclaris Therapeutics CEO Neal Walker's 2021 pay jumps 326% to $6.9M
Aclaris Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 21, 2022
Aclaris Therapeutics reported fiscal year 2021 executive compensation information on April 21, 2022.
In 2021, five executives at Aclaris Therapeutics received on average a compensation package of $4.6M, a 367% increase compared to previous year.
Average pay of disclosed executives at Aclaris Therapeutics
Neal Walker, Chief Executive Officer, received $6.9M in total, which increased by 326% compared to 2020. 60% of Walker's compensation, or $4.1M, was in option awards. Walker also received $387K in non-equity incentive plan, $567K in salary, $1.8M in stock awards, as well as $12K in other compensation.
Joseph Monahan, Chief Scientific Officer, received a compensation package of $5.3M. 90% of the compensation package, or $4.8M, was in stock awards.
Kamil Ali-Jackson, Chief Legal Officer, earned $4.7M in 2021, a 511% increase compared to previous year.
Frank Ruffo, Chief Financial Officer, received $3.3M in 2021, which increases by 302% compared to 2020.
David Gordon, Chief Medical Officer, earned $2.9M in 2021, a 284% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 21, 2022.